Get started
Author

Alexandra Lieberman

Observed name: Alexandra D. Lieberman
Institution: Tulane University
Observed institution: Tulane University
OpenAlex ID: A5021186106
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies
2023 · Albert Jang, Sree M. Lanka, et al. · JCO Precision Oncology · 20
PDF
Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate‐resistant prostate cancer post‐abiraterone and/or enzalutamide
2023 · Albert Jang, Sree M. Lanka, et al. · The Prostate · 6
PDF
Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.
2023 · Albert Jang, Ellen B. Jaeger, et al. · Journal of Clinical Oncology · 4
Evaluation of ctDNA in patients with mCRPC with liver metastases.
2024 · Minqi Huang, Georges Gebrael, et al. · Journal of Clinical Oncology · 1
PDF
Evaluation of ctDNA in patients treated with lutetium-177-PSMA-617.
2023 · Sree M Lanka, Albert Jang, et al. · Journal of Clinical Oncology · 1
Genomic alterations in patients with prostate cancer with liver metastases.
2023 · Crystal Casado, Sydney Caputo, et al. · Journal of Clinical Oncology · 1
PDF
Analysis of TP53 gain of function mutations in metastatic castration-resistant prostate cancer.
2023 · Patrick L Sweeney, Sree M Lanka, et al. · Journal of Clinical Oncology · 1
ctDNA characterization in mCRPC patients with pathogenic germline variants.
2025 · Tivoli Nguyen, Nicholas Habibian, et al. · Journal of Clinical Oncology
PDF
Evaluation of ctDNA alterations in lethal mCRPC.
2025 · Minqi Huang, Nicholas Habibian, et al. · Journal of Clinical Oncology
PDF
68Ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly Study): Preliminary results.
2023 · Charlotte Hawkins, Olivia Pocha, et al. · Journal of Clinical Oncology
PDF
Characterization of ctDNA findings at the end of life in patients with prostate cancer.
2023 · Kanika Gupta, Sydney Caputo, et al. · Journal of Clinical Oncology
Comparison of ctDNA between African American and Caucasian patients with CRPC post abiraterone and/or enzalutamide.
2023 · Albert Jang, Minqi Huang, et al. · Journal of Clinical Oncology
Evaluation of ctDNA in patients with CRPC with pathogenic germline mutations in BRCA2.
2023 · Minqi Huang, Ellen B. Jaeger, et al. · Journal of Clinical Oncology
PDF
Works count: 13
Citation count: 34
H-index: 3
I10-index: 1
Year
Topic
Type